Neurotrophic Keratoconjunctivitis: A Patient Guide
At a Glance
Neurotrophic keratitis is a rare condition in which damaged corneal nerves reduce sensation and impair blinking, tears, and healing. Because the eye may not hurt, regular monitoring and early treatment are essential to prevent ulcers and vision loss.
Neurotrophic keratitis (NK)—sometimes called neurotrophic keratoconjunctivitis—is a rare degenerative condition that affects the cornea, the clear, protective window at the front of your eye. The health of your cornea is managed by the trigeminal nerve, which does much more than just provide sensation; it acts as a vital support system that signals the eye to blink, produce tears, and repair minor surface damage [1]. When this nerve is damaged, the cornea’s ability to maintain and heal itself is severely impaired, leading to a breakdown of the eye’s surface [2].
The defining challenge of this condition is a core paradox: the more the disease progresses, the less you may feel it. Because the sensory nerves are compromised, the eye’s natural “alarm system” is reduced or absent, allowing serious damage to occur without the sharp pain typically associated with eye injuries [1]. This “silent” progression makes the disease a significant threat to your vision, as you may not realize the surface of your eye is deteriorating until your sight begins to blur, the tissue becomes visibly cloudy, or a painless infection takes hold [3].
Physicians categorize the severity of the disease into three stages to guide treatment. It begins with epithelial alterations, where the top layer of the cornea becomes unstable and dry; progresses to persistent epithelial defects, where an open sore develops that refuses to heal; and can eventually lead to stromal ulceration or “melting,” where the deeper layers of the cornea are at risk [1][4]. Because these stages move toward increasing fragility, early recognition and intervention are the most effective ways to preserve long-term vision [5].
Managing this condition requires a proactive partnership with a cornea specialist who understands the unique needs of a “numb” eye. Treatment strategies focus on restoring the protective environment the eye can no longer provide for itself, ranging from the use of specialized preservative-free lubricants to advanced therapies like nerve growth factor drops or surgical interventions to reinforce the corneal structure [6][7]. While a diagnosis can feel overwhelming, a dedicated care plan can help stabilize the eye and support the vital biological processes necessary to keep your vision clear [8].
In this guide
6 chapters
Understanding Neurotrophic Keratitis: Orientation & Overview
Learn what neurotrophic keratitis is, why it may cause little pain, how Mackie stages describe damage, and why early cornea specialist care protects sight.
Why It Happens: Nerve Biology and Common Causes
Learn how nerve damage causes neurotrophic keratitis, including effects on blinking, tears, corneal healing, common causes, and corneal sensitivity testing.
Symptoms, Diagnosis, and the Mackie Staging System
Learn how neurotrophic keratitis affects corneal sensation, how doctors diagnose it, and what Mackie stages mean for corneal damage, vision, and treatment decisions.
First-Line Medical Treatments for Stage 1 and 2
Learn stage 1 and 2 neurotrophic keratitis treatment, including preservative-free tears, serum tears, amniotic membranes, protective lenses, and Oxervate.
Advanced Care: Saving the Eye in Stage 3
Learn how Stage 3 neurotrophic keratitis threatens the cornea and explore tarsorrhaphy, tissue adhesives, flaps, transplants, and neurotization to save the eye.
Daily Care, Monitoring, and Emergency Signs
Learn daily care for neurotrophic keratitis, including preservative-free drops, follow-up monitoring, and emergency signs that need same-day eye care.
Common questions in this guide
What is neurotrophic keratitis, and why can it be painless?
What are the three stages of neurotrophic keratitis?
What symptoms should I watch for if my cornea feels numb?
How is neurotrophic keratitis treated?
Which health conditions may raise the risk of neurotrophic keratitis?
How often should I have my eye checked for neurotrophic keratitis?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Given that this is a 'silent' disease, how often should we be checking my eye surface to catch changes early?
- 2.Are you a cornea specialist with experience specifically in managing neurotrophic keratitis?
- 3.How do you determine which stage of the disease I am currently in?
- 4.What is our plan if the first-line treatments like preservative-free drops aren't enough to stabilize my eye?
- 5.Can you help me understand which of my current symptoms—or lack thereof—are the most important to track?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (8)
- 1
Neurotrophic keratitis: current challenges and future prospects.
Versura P, Giannaccare G, Pellegrini M, et al.
Eye and brain 2018; (10()):37-45 doi:10.2147/EB.S117261.
PMID: 29988739 - 2
Neurotrophic keratitis: inflammatory pathogenesis and novel therapies.
Wajnsztajn D, Faraj LA, Sanchez-Tabernero S, Solomon A
Current opinion in allergy and clinical immunology 2023; (23(6)):520-528 doi:10.1097/ACI.0000000000000942.
PMID: 37694830 - 3
[Clinical picture and diagnosis of neurotrophic keratopathy].
Messmer EM
Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 2019; (116(2)):120-126 doi:10.1007/s00347-018-0822-x.
PMID: 30535856 - 4
Neurotrophic keratopathy: current challenges and future prospects.
NaPier E, Camacho M, McDevitt TF, Sweeney AR
Annals of medicine 2022; (54(1)):666-673 doi:10.1080/07853890.2022.2045035.
PMID: 35243932 - 5
Expert consensus on the identification, diagnosis, and treatment of neurotrophic keratopathy.
Dana R, Farid M, Gupta PK, et al.
BMC ophthalmology 2021; (21(1)):327 doi:10.1186/s12886-021-02092-1.
PMID: 34493256 - 6
Neurotrophic Keratopathy: Current Concepts, Management, and Emerging Treatments.
Cheung AY, Holland EJ
Cornea 2026; (45(6)):673-685 doi:10.1097/ICO.0000000000004055.
PMID: 42085714 - 7
Phase II Randomized, Double-Masked, Vehicle-Controlled Trial of Recombinant Human Nerve Growth Factor for Neurotrophic Keratitis.
Bonini S, Lambiase A, Rama P, et al.
Ophthalmology 2018; (125(9)):1332-1343 doi:10.1016/j.ophtha.2018.02.022.
PMID: 29653858 - 8
Neurotrophic keratopathy: An updated understanding.
The ocular surface 2023; (30()):129-138 doi:10.1016/j.jtos.2023.09.001.
PMID: 37666470
This overview of neurotrophic keratitis is for informational purposes and does not replace medical advice. A cornea specialist or ophthalmologist should assess your corneal sensation, disease stage, and treatment plan.
Get notified when new evidence is published on neurotrophic keratoconjunctivitis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.